NanoImaging Services, Inc. Overview
Pro stress-test →NanoImaging Services is a US-based CRO with in-house microscopes offering protein production and cryo-EM services to support both structure-based drug design and nanoparticle characterization. Following strategic acquisitions, NIS has become the largest and most comprehensive provider of TEM and cryo-EM services to the industrial life science market. The company serves pharmaceutical and biotechnology customers requiring advanced imaging solutions for accelerated drug discovery and development workflows.
Strategic Profile
Pro stress-test →NanoImaging Services is a US-based Contract Research Organization specializing in cryo-electron microscopy services aimed at accelerating drug discovery, offering structural biology, nanoparticle characterization, and GMP compliant imaging supported by in-house microscopes. In March 2026, the company appointed Fraser McLeod as Chief Executive Officer. Following its acquisition of Proteos in 2024, the company also offers recombinant protein production across multiple expression systems and integrated gene-to-structure workflows for drug discovery and development.
Competitive Landscape
Pro stress-test →NanoImaging Services competes in the contract research organization (CRO) space focused on structural biology and drug discovery support. According to PitchBook, Shanghai Medicilon is identified as one of NanoImaging Services's competitors. The market includes both specialized cryo-EM providers and full-service protein/structural biology CROs. NIS differentiates through integrated gene-to-structure workflows, GMP capabilities, and remote access technology.
Industry Context
NanoImaging Services, Inc. operates in Contract Research Organizations (Cryo-EM and Structural Biology).
Key facts
Founded: 2007 · Headquarters: San Diego, California · Employees: 52